United Therapeutics Corporation
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2022
Total Assets: $6.04B
Liabilities Breakdown FY2022
Total Liabilities: $1.25B
Asset Breakdown
Total Assets: $6.04B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $961.2M | 15.9% |
| Accounts Receivable | $220.4M | 3.6% |
| Inventory | $102.0M | 1.7% |
| Property, Plant & Equipment | $861.5M | 14.3% |
| Goodwill | $28.0M | 0.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.87B | 64.0% |
Liabilities Breakdown
Total Liabilities: $1.25B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.1M | 0.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.24B | 99.7% |